Diagnóstico y tratamiento de trastornos hipertensivos del embarazo
Descripción del Articulo
Hypertensive disorders of pregnancy, especially preeclampsia, represent a major cause of maternal and perinatal morbidity and mortality worldwide. This comprehensive review explores the epidemiology, classification, diagnosis, and management of these conditions. The prevalence of hypertensive disord...
| Autores: | , |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2026 |
| Institución: | Fundación Instituto Hipólito Unanue |
| Repositorio: | Diagnóstico |
| Lenguaje: | español |
| OAI Identifier: | oai:revistadiagnostico.fihu.org.pe:article/633 |
| Enlace del recurso: | https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/633 |
| Nivel de acceso: | acceso abierto |
| Materia: | Pre-eclampsia eclampsia hypertension maternal health Preeclampsia hipertensión salud materna |
| Sumario: | Hypertensive disorders of pregnancy, especially preeclampsia, represent a major cause of maternal and perinatal morbidity and mortality worldwide. This comprehensive review explores the epidemiology, classification, diagnosis, and management of these conditions. The prevalence of hypertensive disorders of pregnancy varies by geographic region, beinghighest in developing countries. Risk factors such as advanced maternal age, obesity, preexisting diabetes, family history of preeclampsia, and multiple pregnancy significantly increase the risk. The main hypertensive disorders of pregnancy aredescribed, including gestational hypertension, preeclampsia, preeclampsia with severe features, eclampsia, chronic hypertension, and superimposed preeclampsia. Diagnosis is based on clinical criteria, such as elevated blood pressure and proteinuria, and may require additional laboratory tests to assess liver and kidney function. Management of hypertensive disorders of pregnancy depends on the severity of the disease and gestational age. The main goal is to prevent maternal and fetal complications and to ensure a favorable maternal and neonatal outcome. Treatment may include pharmacological measures to control blood pressure, close fetal monitoring, and in some cases, premature delivery. |
|---|
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).